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Nitric oxide (NO) and hydrogen sulﬁde (H2S) have emerged as dominant redox regulators of numerous
aspects of cellular and physiological functions within several organ systems included cardiovascular,
immune and neurological tissues. Recent studies have begun to reveal that these two gaseous molecules
may have redundant or overlapping pathophysiological functions often involving similar molecular
targets. However, it remains less clear when and how NO and H2S may interact under biological and
disease processes. In this graphical review, we discuss the current understanding of NO and H2S
interactions and how they may functionally inﬂuence each other and what this may mean for biology
and mechanisms of disease.
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Nitric oxide (NO) has been extensively studied over the last
three decades for its role in vascular functions and as a signaling
molecule [1]. Nobel winning works from the trio Furchgott, Murad
and Ignarro has placed NO as a central endothelial-derived
relaxing factor (EDRF) and a key regulator of cardiovascular
pathophysiological responses. However, the role of this gaseous
molecule is being re-evaluated with the appreciation of a new
gasotransmitter hydrogen sulﬁde (H2S) that also serves manyr B.V.
ogy, LSU Health-Shreveport,
Open access under CC BY-NC-SAimportant regulatory roles in physiological systems. Like NO, H2S
was once thought to simply be a toxic gas but it is now believed to
be an important redox-signaling molecule. A decade of studies on
H2S biology have elucidated its role in regulation of vascular
homeostasis, neurological function, cytoprotection, anti-inﬂam-
mation, revascularization and therapeutic angiogenesis; along
with modulation of cell survival responses, which is similar to
many physiological roles of NO.
Production of either molecule occurs through enzymatic and
non-enzymatic pathways. Fig. 1 illustrates H2S formation via the
transulfuration pathway involving CBS and CSE along with
cysteine catabolism via MST. It is also possible that H2S may be
obtained through reductive chemistry on thiosulfate, thiocystine
and other molecules. Similarly, NO formation predominantly
occurs through nitric oxide synthases (NOS's); however, it is
increasingly apparent that non-enzymatic generation of NO via
various nitrite/nitrate reduction mechanisms also critically regu-
lates bioavailability. The physiological functions of NO [2–4] and license.
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Fig. 1. Biosynthesis of NO and H2S: NO and H2S are enzymatically synthesized by three enzymes. H2S is generated from oxidation of the substrates L-homocysteine,
cystathionine, L-cysteine and 3-mercaptopyruvate through the enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) and 3-mercaptopyruvate
sulfurtransferase (3-MST). α-ketobutyrate, lanthionine, L-serine and pyruvate are the secondary products formed. NO is produced by three NOS isoforms neuronal,
inducible and endothelial NO synthase (nNOS, iNOS and eNOS) that catalyze the oxidation of L-arginine to L-citrulline; Alternatively, production of H2S occurs non-
enzymatically from various storage forms of sulfur like thiosulfate, thiocysteine and sulﬁte; whereas NO is produced through reduction of nitrite/nitrate under low oxygen
conditions.
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literature. However, the interrelation of NO–H2S and their subse-
quent biochemical interactions are complex and currently unclear.
While some studies have shown that NO/H2S positively affect each
other's production and function [8–10]; other studies report
contrarian, if not directly opposite ﬁndings [11–13]. Thus, signiﬁ-
cant ambiguity remains regarding NO–H2S chemical interactions
and subsequent biological effects. This graphical review discusses
the latest understanding of the relationship between these two
gaseous signaling molecules and their roles in regulating several
biological functions along with important future directions for
research.cGMP
PKG
sGC
GTP
Ras/Raf
ERK/p38 MAPK
EC Migration, Proliferation
and Angiogenesis
Fig. 2. Common signaling pathways of H2S and NO: H2S and NO mediated vascular
remodeling aspects through common pathway that include VEGF, HIF-1α, PI3K/AKT
upregulated by H2S. PI3K/AKT induces NOS/NO. H2S directly effects NO through XO
mediated nitrite. Both NO and H2S are independently involved in upregulating
cGMP; H2S acts through K-ATP and PDE5, NO activates enzyme sGC to increase
cGMP production that has downstream signaling effects of EC migration, prolifera-
tion and angiogenesis via PKG/Ras–Raf/ERK-p38 MAPK axis.NO–H2S signaling
To date, only a small number of reports suggest that NO–H2S
molecules may inﬂuence each other in their production and
pathophysiological functions [5,14]. Studies demonstrate a com-
mon signaling pathway where NO–H2S crosstalk mediates their
effects on vascular functions such as vasodilation, vascular remo-
deling (migration and proliferation) and angiogenesis [10,14–16].
Recent studies demonstrate H2S mediated upregulation of NO and
vice-versa in regulating angiogenesis and attenuation of ischemia
reperfusion (I/R) injury [14,15,17,18]. Fig. 2 illustrates that pro-
angiogenic and I/R injury protection of H2S and its donors may
occur through induction of VEGF/VEGFR2 signaling and its down-
stream effectors such as PI3K/Akt/eNOS in the vascular endothelial
cells [8,10,19,20]. Moreover, H2S has been reported to prevent
eNOS degradation and induce eNOS phosphorylation with subse-
quent NO production via PI3K/Akt activity [21,22] and p38 MAPK
pathways [23]. H2S therapy can also preserve mitochondrial
function and modulate cardioprotection through attenuation of
oxidative stress via VEGF/Akt/eNOS/NO/cGMP pathway [8]. Reci-
procally, pharmacological donors of NO can up-regulate substrate
bioavailability for and expression of the H2S synthesis enzyme
cystathionine gamma lyase (CGL/CSE) resulting in H2S production
eliciting vasodilatory effects [14,24–26]. However, it has beenreported that use of an NO donor can inhibit CBS expression
counteracting what has been shown for CGL [13]. Finally,
studies have shown that H2S has opposing effects on NOS/NO
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activity of eNOS and subsequent NO production involving altered
L-arginine/BH4, increased HO-1/CO and other unknown mechan-
isms [11,12,27,28].
Hydrogen sulﬁde also potently regulates cellular redox balance
necessary for cytoprotection and inhibition of oxidative stress
(Fig. 3). Studies have shown that exogenous H2S stimulates Nrf2
activation leading to increased anti-oxidant defense responses
[29,30]. Moreover, H2S therapy has been reported to blunt NOX1
expression and activity thus alleviating oxidative stress [31]. H2S
exerts anti-inﬂammatory protection of organs exposed to I/R
injury through an eNOS/NO and p38 MAPK dependent mechan-
ism. Importantly, this protective effect of H2S is not evident in
eNOS−/− mice [32]. Similar observations are found upon inhibition
of eNOS and subsequent NO production attenuating H2S-mediated
vascular responses including vasorelaxation and angiogenesis [17].
These observations indicate that H2S can mediate its effects
through a NO dependent pathway. Likewise, chemical inhibition
of CSE inhibits NO-mediated vascular functions, suggesting its
interdependency on H2S [17]. However, our group has found that
H2S therapy is beneﬁcial for ischemic vascular remodeling in
eNOS−/− mice involving alternative non-enzymatic generation of
NO via xanthine oxidase (XO) mediated nitrite reduction that
increases tissue VEGF, cGMP production and angiogenesis activity
under ischemic conditions [15].
The role of NO as a potent vasodilator through activation of
soluble guanylate cyclase (sGC) and subsequent cGMP production
is well established [33]. Likewise, H2S can exhibit vasodilatory
effects indirectly by delaying cGMP degeneration through PDE5
inhibition [34]. However, H2S may also trigger dose-dependent
vasoconstriction or dilatory effects depending on type of the vessel
and the animal species examined. This conditional response
toward H2S is mediated though chemical modiﬁcation of potas-
sium channel protein thiols [5,35,36] or due to nitrosothiol formed
as a result of NO/H2S interaction [36]. Studies with speciﬁc
knockouts of NOS or CSE further substantiate the vasodilatory
effect of NO/H2S [37,38]. Moreover, a concept is emerging whereby
H2S induces eNOS/NO production by Ca2+ release that may also
contribute to vasodilation [19]. In contrast, chemical inhibition of
CSE attenuates NO mediated cGMP formation, vasodilation and
angiogenesis [17]. Together, these reports suggest an importantNrf2
HO-1 ROS
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NOX
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Fig. 3. NO and H2S redox regulations and cytoprotection: (1) Reactive oxygen species a
superoxide radical (dO2−). Superoxide radical is formed from the mitochondrial comple
Nitrite/NO regulates NOX that upregulates H2O2 thereby contributing to ROS. (2) Bot
complexes I and IV and the intermediary component cytochrome C that generate ROS
production. Nrf2 also induces HO-1 mediated inhibition of ROS.role for H2S in NO mediated vascular effects. Nevertheless, it
appears that NO–H2S and their enzymatic pathways may be
mutually interactive and inﬂuence various biological functions.
Additional studies are desperately needed to understand this
complex relationship that has signiﬁcant potential to advance
our understanding of redox regulation of vascular reactivity.Posttranslational modiﬁcations
Protein posttranslational modiﬁcations (PTM's) play signiﬁcant
roles in affecting not only the structure and interaction of proteins,
but also regulating physiological functions through activation of
various signaling pathways [39–41]. Fig. 4 shows that thiol
residues of proteins may undergo different PTM through reactions
with various biochemicals (e.g. H2S/HS−, NO or GSH) thereby
affecting protein function. Active Cys residues at enzymes sites
with low pKa can exist predominantly as thiolate anions (S−) that
are strong nucleophiles and interact with ROS species to generate
sulfenic acid (SOH) (panel 4A), which can readily react with HS− or
H2S to form a persulﬁde bond [42]. NO also participates in
modulating signaling function in a similar way through protein
thiol S-nitrosation. This predominantly occurs due to NO radical
(or other RNS species) oxidation of protein free thiol (RSH) with a
nitrosyl group at the cysteine to form S-nitrosothiol [43]. This
modiﬁed S-nitrosothiol may be much less reactive than the
original thiol group resulting in reduced reactivity of cysteine.
Thus, H2S mediates protein modiﬁcations through persulﬁdation
(also known as ‘sulfhydration’), similar to nitrosation by NO.
H2S modiﬁes Cys residues of the proteins where the sulfhydryl
group of cysteine is converted to an –SSH group (panel 4B). This
modiﬁed cysteine residue is highly reactive and increases the
catalytic activity of targeted proteins. For instance, Glyceraldehyde
3-phosphate dehydrogenase (GAPDH), a glycolytic enzyme can be
modiﬁed both by S-nitrosylation and S-sulfhydration at Cys-150
[40]. While, NO inhibits catalytic activity of GAPDH, H2S increases
it. Interestingly, other enzymes such as protein tyrosine phospha-
tases (PTP) are also regulated by NO and H2S through protein
modiﬁcations. NO modiﬁes PTP-1B by S-nitrosation at cysteine
215 residue, which prevents inactivation by H2O2 induced irrever-
sible oxidation [44]. It has been reported that H2S typicallyNO
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Fig. 4. Protein modiﬁcations mediated by NO and H2S: (A) Oxidation of free thiol leads to form thiolate. A series of oxidation reactions can take place in the presence of
increasing reactive nitrogen or oxygen species that can oxidize thiolate (protein-S-) to sulfenic acid (protein–SOH) further irreversibly oxidize to sulﬁnic (protein–SO2H) and
sulfonic acid (protein–SO3H). (B) Reduction of disulﬁdes forms thiols. A free thiol decoupled from disulﬁde can react with either H2S to form –SSH group through
persulﬁdation (sulfhydration) or may form nitrosothiol by reacting with dinitrogen trioxide (N2O3) that is formed from nitrite and a NO radical (NOd). SNO formation occurs
when NO reacts with a thiol and to form NO, likewise SNO can also release NO. SNO can be modiﬁed into glutathionylated thiol (protein–SSG) in presence of a GSH or can
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Fig. 5. Potential NO–H2S chemical interactions: Radicals of NO (NOd) and H2S (HSd)
leads to formation of thionitrous acid (HSNO). HSNO formation can also occur from
reaction between sodium nitroprusside (SNP) either with RSNO or H2S. Alterna-
tively the anionic form of H2S, hydrosulﬁde ion (HS−) can react with a nitrosating
species leading to form HSNO. Peroxynitrite reacts with H2S to form sulﬁnyl nitrite
(HSNO2), which further dissociate into NOd and HSOd. HSNO can react with H2S to
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however, with PTP1B Cys persulﬁde formation inactivates the
enzyme in a reversible manner contributing to ER stress response
effects on PTP enzyme function. Importantly, PTP1B persulﬁdation
also occurs on cysteine 215, which is preferentially reversed
by thioredoxin/thioredoxin reductase versus other intracellular
reduction pathways highlighting the thiol persulﬁdation (sulfhy-
dration) may act in a sensitive manner to control cellular physiol-
ogy [45]. Together, these recent studies suggest that persulﬁdation
may be more prevalent than nitrosylation and possibly equivalent
to phosphorylation in regulating various biological functions;
however, comprehensive studies examining thiol modiﬁcation
states are necessary in order to understand the magnitude and
degree of various thiol PTM [40,45–47]. It is intriguing that both
NO and H2S can target the same reactive Cys residues of a given
protein that diversely impacts catalytic activity and function of the
protein revealing complex regulatory mechanisms that are not
fully understood. Additionally, it is also unclear what role post-
translational thiol modiﬁcation by glutathione plays in modulating
nitrosation versus persulﬁdation in an ever-evolving paradigm of
redox signaling. It is clear that more work is needed to better
understand when these various PTM's form, the prevalence of
them in biological systems, and their functional effects under
physiological and pathological conditions.form nitroxyl (HNO), and HSNO upon hydration (H2O) can lead to nitrite formation.
HNO is also formed from L-arginine through a reaction of peroxynitrite. Finally,
HNO can further dissociate into hydroxylamine on reacting with glutathione (GSH),
releasing GSSG in this process, which can in turn react with HNO forming NO.Novel molecules from NO–H2S interaction
Both NO and H2S are chemically reactive gaseous molecules that
are generated and distributed across various tissues. The nucleo-
philic properties of H2S and metabolites and electrophilic charac-
teristics of NO metabolites suggest a possible cross talk between
metabolite products of these two gaseous molecules forming new
intermediates (Fig. 5). Although, it is important to understand that
direct reaction between H2S and NO is chemically unfavorable thusopening the possibility of ionic metabolite interactions. Early
observations from Kimura and co-workers suggested that H2S and
NO serve a coordinated relationship in regulating the vascular tone
[48]. Later, Whiteman and colleagues reported potential antioxidant
effects of H2S through its interaction with peroxynitrite (ONOO−)
G.K. Kolluru et al. / Redox Biology 1 (2013) 313–318 317[49]. A follow up study from this group further suggested that NO
and H2S may react to form a novel nitrosothiol that has not been
further characterized [50,51]. However, more recent studies have
demonstrated that NO/H2S metabolites can react forming novel
chemical products that could uniquely inﬂuence biochemical and
physiological responses [52–56].
NO can react with oxygen radicals to form secondary reactive
nitrogen species such as N2O3 or ONOO−, as well as S-nitrosation
reactions with protein and small molecular weight thiols resulting
in S-nitrosothiols (RSNO) affecting numerous redox dependent
processes. NO oxidation products such as nitrite, nitrate, N2O3,
nitrosothiols and other NO metabolites such as electrophilic-
nitrated fatty acids can react with H2S. While it is most unlikely
that a direct interaction between H2S and NO occurs; HS− may
react with either oxidized form of NO, NOd or nitrosating species
(formed through reaction with NOd, O2−d and ONOO−) or SNO/
GSNO to form novel molecules like nitrosothiol, sulﬁnyl nitrite (HS
(O)NO or HSNO2) or nitroxyl (HNO) with less clear physiological
implications. Importantly H2S, at therapeutic concentrations (low
to mid micromolar) inhibit cytotoxic effects of peroxynitrite
possibly through formation sulﬁnyl nitrite, a precursor that may
also form HNO. This novel product of H2S and ONOO− has the
potential to release NO while simultaneously neutralizing pro-
apoptotic and oxidative effects of peroxynitrite [55].
H2S by itself may react with RSNO to form thionitrous acid
(HSNO) [27,51]. Intracellular formation of HSNO, under physiolo-
gical conditions is still debatable. However, its production through
NO [57], cytochrome c [58] and heme containing enzymes [59]
has been reported. HSNO has been shown in vitro to diffuse
intracellularly and facilitate transnitrosation of proteins such as
hemoglobin. HSNO can be metabolized to generate NO and
other NO species like HNO that has presumably longer half-
life and may have physiological roles in oxygen delivery and
cardioprotection [53].
Nitroxyl (HNO), a protonated form of NO, is highly reactive to
nucleophiles such as thiols. Recent studies demonstrate that HNO
can have distinct physiological functions such as vasodilation and
cardioprotection especially at low concentrations [20,60]. The
effects of HNO in cardioprotection may also occur through cGMP
[61]. On the contrary, there are also reports suggesting that HNO
can be neurotoxic, cause inﬂammation and arrhythmia, DNA
oxidation and thiol loss at much higher concentrations than what
would be considered a therapeutic dose [20,62,63]. These studies
suggest careful use considering their signiﬁcant toxicity at high
concentrations. Extensive studies of these various reaction pro-
ducts between H2S and NO require further experimentation to
understand complex biochemical signaling mechanisms between
these mediators for various biological functions.Conclusion
It is evident from the literature that the two “gasotransmitters”
NO and H2S perform a variety of homeostatic physiological
functions. Both of these molecules are implicated in signaling of
many complex pathways under physiological and pathological
conditions. Though there are few studies demonstrating NO–H2S
interplay, it is also unclear whether the kinetics of NO–H2S
reaction and formation of novel compounds may be biologically
signiﬁcant compared to the presence and amount of other mole-
cules (e.g. GSH). Considering the concentration dependent effects
of NO and H2S, careful attention to bioavailable levels of these
molecules will be critical to determine the likelihood that various
reactions or interactions may occur to inﬂuence molecular and
cellular physiological responses. Moreover, it will also be impor-
tant for studies focusing on NO–H2S interactions to evolve fromtheoretical and test tube levels to cellular and pathophysiological
models if we are to truly understand the relationship between NO
and H2S interactions. Given the novelty of this area, it is likely that
new and exciting discoveries will be revealed detailing gaseous
mediator regulation of redox biology.Acknowledgments
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